In summary, this study demonstrated that RHAS could improve systemic immune response by elevating the Th1/Th2 cell ratio and decreasing the levels of IgE and IL-4, thereby effectively preventing the recurrence of allergic asthma. The gene discussed is IL4; the disease is allergic asthma.